Navigation Links
Most Read Pharmaceutical and Health News - March '13
Date:4/23/2013

AUSTIN, Texas, April 23, 2013 /PRNewswire/ -- dailyRx News Network announced today the most popular health topics viewed and shared during March 2013. dailyRx News publishes and syndicates consumer-centric health information across YouTube, mobile apps, various news aggregators, as well as through a national network of healthcare providers' social media channels.

"As the digital age evolves, a growing number of adults are using their smartphones and tablets to research health news and information," said Donald W. Hackett , CEO and Publisher of dailyRx News. "It is important that on-the-go eHealth consumers have access to a trusted digital health news resource at their fingertips," Hackett added.

According to Pew Research Center's Project for Excellence in Journalism, digital news consumption was up to 50% in 2012, increasing from 44% in 2010. In addition, a study by InSite Consulting found that 42% of people turn to TV as their primary and initial device in breaking news situations, with 66% then using the Internet to further investigate stories.

Health conditions generating notable viewer engagement on dailyRx.com last month included:

March's most-viewed medications included:

Trending health news throughout dailyRx social media included:

About dailyRx News Network
dailyRx News Network is an emerging leader in publishing health news for consumers and patients alike. dailyRx publishes, aggregates, and syndicates doctor-reviewed news covering a wide range of health conditions, medications, over-the-counter products, and nutraceutical compounds. dailyRx's original content is written in positive, unbiased, easy-to-understand language and reviewed for accuracy by doctors, pharmacists, and therapists. dailyRx, Inc. is a Patient Conversation Media company.


'/>"/>
SOURCE dailyRx News Network
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. European Nuclear Medicine / Radiopharmaceuticals Market - Global Trends & Forecasts to 2017
2. Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
3. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
4. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
5. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
6. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
7. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
8. Comparison of Biopharmaceutical Industry Between China and India 2013
9. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
10. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
11. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... , ... SuperCloset is proud to officially launch our “Helping Veterans Grow ... and obstacles veterans’ need to overcome in order to face their life changes upon ... veteran(s) with a donated SuperCloset product based on the needs and ability of helping ...
(Date:5/27/2016)... ... ... More than a third of American adults are considered obese, says the ... increased attention in recent years, as an article published May 18th on ... people are familiar with the basic requirements of maintaining a healthy diet and exercise ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... health care world, this installment is bolstered by inspiring human interest stories, courtesy ... to the developing trends and tech within the industry, from leading advocates and ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
Breaking Medicine News(10 mins):